ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $90,964,000 | +419.9% | 528,554 | +279.1% | 0.03% | +433.3% |
| Q2 2021 | $17,497,000 | +11.8% | 139,425 | +20.9% | 0.01% | -14.3% |
| Q1 2021 | $15,645,000 | +348.7% | 115,366 | +323.3% | 0.01% | +600.0% |
| Q4 2020 | $3,487,000 | -52.1% | 27,256 | -57.9% | 0.00% | -80.0% |
| Q3 2020 | $7,277,000 | -75.5% | 64,673 | -79.3% | 0.01% | -78.3% |
| Q2 2020 | $29,738,000 | +302.1% | 312,143 | +279.4% | 0.02% | +228.6% |
| Q1 2020 | $7,395,000 | +1558.1% | 82,280 | +629.0% | 0.01% | +600.0% |
| Q3 2019 | $446,000 | +34.7% | 11,286 | +40.2% | 0.00% | 0.0% |
| Q2 2019 | $331,000 | +32.4% | 8,048 | +25.7% | 0.00% | 0.0% |
| Q1 2018 | $250,000 | -43.9% | 6,404 | -39.1% | 0.00% | 0.0% |
| Q4 2017 | $446,000 | -69.5% | 10,519 | -73.1% | 0.00% | -80.0% |
| Q3 2017 | $1,461,000 | +558.1% | 39,137 | +758.8% | 0.01% | +400.0% |
| Q4 2015 | $222,000 | -55.3% | 4,557 | -68.8% | 0.00% | -83.3% |
| Q2 2014 | $497,000 | – | 14,621 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |